Skip to main content

Table 1 Baseline characteristics including demographic and laboratory data of the study population

From: Angiopoietin-1 is associated with cerebral vasospasm and delayed cerebral ischemia in subarachnoid hemorrhage

Parameter

dCVS absent

dCVS present

p-value

number of patients

9

11

 

age (mean, range)

52.6 (31-66)

51.9 (39-64)

0.655*

female gender, n (%)

8 (88.9%)

8 (72.7%)

0.369†

WFNS scale, n (%)

  

0.119†

I

4 (44.4%)

3 (27.3%)

 

II

0 (0%)

4 (36.4%)

 

III

2 (22.2%)

0 (0%)

 

IV

1 (11.1%)

3 (27.3%)

 

V

2 (22.2%)

1 (9.1%)

 

Fisher grade, n (%)

  

0.243†

II

2 (22.2%)

0 (0%)

 

III

2 (22.2%)

4 (36.4%)

 

IV

5 (55.6%)

7 (63.6%)

 

mRS on discharge

  

0.545†

0

3 (33.3%)

4 (36.4%)

 

1

3 (33.3%)

1 (9.1%)

 

2

0 (0%)

1 (9.1%)

 

3

1 (11.1%)

3 (27.3%)

 

4

0 (0%)

1 (9.1%)

 

5

1 (11.1%)

0 (0%)

 

6

1 (11.1%)

1 (9.1%)

 

Length of stay in days, mean (range)

20.3 (9-41)

25.5 (12-53)

0.394*

Occlusive hydrocephalus requiring EVD

3 (33.3%)

7 (63.6%)

0.178†

Ventriculo-peritoneal shunt

1 (11.1%)

1 (9.1%)

0.881†

Intracerebral hemorrhage

3 (33.3%)

3 (27.3%)

0.769†

Cerebral edema

5 (55.6%)

8 (72.7%)

0.423†

  1. dCVS: Doppler sonographic cerebral vasospasm, WFNS: World federation of neurosurgical societies, mRS: modified Rankin scale, EVD: external ventricular drainage, Ang-1: angiopoietin-1, Ang-2: angiopoietin-2. * Analysis of variance, † chi-square test.